Latest Posts

The most recently published posts in all categories.

Pharmaceutical Executive Sentenced To 66 Months In Prison In Opioid Trial


The sentencing of a former pharmaceutical executive to more than five years in prison is being hailed as a potentially important warning to other pharmaceutical executives. Although this trial will hopefully signal the start of other prosecutions, it is also remarkable such prosecutions aren't already common. Reports indicate that in the United States alone more ...Read more

Benzodiazepine prescriptions reach ‘disturbing’ levels in the US


This article reports on a disconcerting trend -- a high level of benzodiazepine prescription in the US and abroad. In too many cases, the benzodiazepine's were co-prescribed with opioids even though the combination of the two can be fatal.  The article also points out that benzodiazepine deaths have gone up substantially in the US over ...Read more

The medications that change who we are


An interesting article concerning possible personality and other changes caused by commonly available, prescribed or over-the-counter drugs. While the article relates to drugs other than those typically associated with addiction or addiction treatment, it would also seem to raise a red flag for the widespread, indiscriminate use of drugs.  If, as the research suggests, commonly ...Read more

Disease Model Proponents Are the Climate Change Deniers of Our Field


An important statement of the problem and consequences of adopting an overly-medicalized view of addiction. In part, it says:  "Convincing us that addiction is inevitable and inescapable—in the face of ubiquitous evidence that it is culturally and cognitively inculcated and very escapable—is a self-fulfilling prophecy. (Unlike addiction, people don’t generally escape diseases like cancer through ...Read more

Purdue Pharma’s Foreign Affiliate Now Selling Overdose Cure


This article covers the history of Purdue Pharma playing both ends of the problem -- providing opioids that lead to addition and other drugs for those who become addicted.  This serves as a cautionary tale for communities considering drug-based "solutions" to the opioid crisis. The player with the largest marketing budget is Big Pharma and ...Read more

FDA Warning Against False MAT Advertising


This article covers the latest in a long history of misrepresentations by the industry about opioid-related drugs. It is well known that the pharmaceutical industry contributed materially to the current opioid crisis and has routinely engaged in problematic marketing practices. For example, see: 76 billion opioid pills: Newly released federal data unmasks the epidemic Deciphering ...Read more

The Drugging of the American Boy


An article from several years ago that points out the disconcertingly high rate at which American boys are drugged for behaviors that previously would have been considered natural. At the time of the article approximately 20% of boys were being prescribed schedule II drugs which are "defined as having a 'high potential for abuse' and ...Read more

PhRMA ends funding for high-profile addiction treatment group


The Addiction Policy Forum, a non-profit which has been the subject of some concern because of its financial ties to the pharmaceutical industry, is now losing that support.  For background on the concern, see Big Pharma Co-Opts Anti-Addiction Advocate. This article claims the Addiction Policy Forum received upwards of 90% of its funding from a pharma ...Read more

Multiple Pathways of Recovery 2019 Second Day Keynote


The beat of drums marked the start of Day 2 of the Multiple Pathways of Recovery Conference (MPRC). This morning’s keynote speaker was Don Coyhis of the Mohican Nation who began his presentation by introducing native American musicians whose traditional drumming and singing called attendees together. Coyhis is the President and Founder of White Bison, …Read more